Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergTrump Targets $128 Billion ...

FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...

THE Philippines plans to import liquefied natural gas (LNG) from Alaska to meet its growing energy needs, the nation’s envoy ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

Tokyo Gas has acquired a 20% stake in FGEN LNG, the owner and operator of an offshore floating liquefied natural gas (LNG) ...

The deal involves an enterprise value of $85 million plus approximately $75 million in net cash held by FibroGen in China at the time of closing, totaling around $160 million. This strategic move will ...

FibroGen sells its China unit to AstraZeneca for $160 million, extending its cash runway into 2027 and advancing its ...

FibroGen today announced the sale of its China subsidiary to UK pharma major AstraZeneca for around $160 million, with the ...

A California-based biotech turned heads on Thursday following an announcement that the company has agreed to sell its China ...

H.C. Wainwright analyst Matthew Keller keeps a Buy rating on FibroGen (FGEN) with a $10 price target after the company announced the sale of ...

AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.

Tokyo Gas Co. Ltd, Japan’s largest natural gas utility company, officially entered the Philippine market with the acquisition ...